News tagged with cancer growth
Related topics: cancer cells , cancer , breast cancer , tumor growth , cells
Stem cell finding could advance immunotherapy for lung cancer
A University of Cincinnati (UC) Cancer Institute lung cancer research team reports that lung cancer stem cells can be isolated—and then grown—in a preclinical model, offering a new avenue for investigating immunotherapy ...
Cancer
Nov 13, 2012 |
4.5 / 5 (2) |
0
|
For brain tumors, origins matter
(Medical Xpress)—Since stem cells and progenitor cells are regulated by different growth factors, brain tumors arising from these cells might respond differently to different therapies. Researchers at Sanford-Burnham ...
Cancer
Nov 13, 2012 |
not rated yet |
0
|
A comparative medicine study identifies new approach to combat viral infections
When a virus such as influenza invades our bodies, interferon proteins are among the first immune molecules produced to fight off the attack. Interferon can also play a role in suppressing tumor growth and ...
Medical research
Nov 09, 2012 |
5 / 5 (3) |
1
|
Researchers identify novel metabolic programs driving aggressive brain tumors
Researchers at Moffitt Cancer Center have identified metabolic signatures that may pave the way for personalized therapy in glioma, a type of tumor that starts in the brain.
Cancer
Nov 09, 2012 |
4 / 5 (1) |
0
|
Breast cancer drug geldanamycin could halt other tumors
A drug commonly used in treating breast cancer could have far wider benefits, offering a new way of preventing cancers spreading through the body, according to a University of Leeds-led study.
Cancer
Nov 06, 2012 |
4.8 / 5 (4) |
0
|
Hedgehog pathway key in tamoxifen-resistant breast CA
(HealthDay)—Noncanonical Hedgehog (Hh) signaling is activated in tamoxifen-resistant tumors, and the phosphoinositide 3-kinase inhibitor/protein kinase B (PI3K/AKT) pathway plays a key role protecting Hh ...
Cancer
Nov 06, 2012 |
not rated yet |
0
Temple researchers show targeted cancer drug may stunt heart's ability to repair itself
Scientists for the first time have evidence showing how a widely used type of "targeted" cancer drug can be dangerous to the heart.
Cardiology
Nov 06, 2012 |
4 / 5 (2) |
0
|
Information aids influence more to get screened for colon cancer
People who are given information tools to help them decide whether to have a colorectal cancer screening test are more likely to request the procedure, finds a new study in the American Journal of Preventive Me ...
Cancer
Nov 06, 2012 |
not rated yet |
0
New finding gives clues for overcoming tamoxifen-resistant breast cancer
(Medical Xpress)—A University of Cincinnati (UC) cancer biology team reports breakthrough findings about specific cellular mechanisms that may help overcome endocrine (hormone) therapy-resistance in patients ...
Cancer
Nov 02, 2012 |
not rated yet |
0
|
Adverse prognostic factor ID'd in operable breast cancer
(HealthDay)—For women with operable breast cancer, moderate immunohistochemical expression of human epidermal growth factor receptor (HER)-2 (2+) without amplification of HER-2 (HER-2 2+/HER-2−) is an adverse prognostic ...
Cancer
Oct 30, 2012 |
not rated yet |
0
Genes may determine aspirin's effect on advanced colon cancer
(HealthDay)—For patients suffering from advanced colorectal cancer, aspirin may prolong their lives if their tumor has a certain gene mutation, a new study finds.
Cancer
Oct 24, 2012 |
not rated yet |
0
Compound's dual action inhibits oral cancer without observable side effects
The compound licofelone inhibited oral cancer growth by inhibiting the cyclooxygenase and 5-lipoxygenase pathways, with no observable side effects, according to data from a rat study presented at the 11th Annual AACR International ...
Cancer
Oct 19, 2012 |
not rated yet |
0
Mechanisms of action for green tea extract in breast cancer prevention identified
An oral green tea extract, Polyphenon E, appears to inhibit vascular endothelial growth factor and hepatocyte growth factor, both of which promote tumor cell growth, migration and invasion.
Cancer
Oct 18, 2012 |
5 / 5 (1) |
0
Painless skin rash predicts survival benefit from latest lung cancer drug, study finds
(Medical Xpress)—Elderly patients with advanced non small cell lung cancer (NSCLC) who developed a rash within 28 days of receiving the targeted drug erlotinib (Tarceva) survived on average 6.2 months, c ...
Cancer
Oct 17, 2012 |
not rated yet |
0
Targeting cancers' 'addiction' to cell-cycle proteins shuts down tumors in mice
In what they say is a promising and highly selective treatment strategy, scientists at Dana-Farber Cancer Institute have safely shut down breast cancer and a form of leukemia in mice by targeting abnormal proteins to which ...
Cancer
Oct 16, 2012 |
5 / 5 (1) |
0
